news2025 Year In Review

We hope your 2026 is off to a great start! We’re excited to share that FFL had another productive year, thanks to our hyperspecialized, high-engagement Sector Exploration and Expertise Development (“SEED”) strategy.

We are proud to partner with businesses and management teams that we consider best-in-class. We believe the high quality of our investments has enabled us to consistently deploy capital and return proceeds to our investors.

Highlights from the past year:

• We completed an attractive proprietary investment in Janus Rx, representing the culmination of a longstanding SEED
• On average, our portfolio companies generated 20%+ organic year-over-year revenue and EBITDA growth
• We successfully exited two investments: Eyemart Express to VSP Vision and Anova to Aurora Capital Partners, contributing to $500M+ in proceeds realized in the past year
• We completed a merger within our portfolio between Abacus Group and Medicus IT to create a leading IT managed service provider focused on financial services and healthcare clients
• We made five well-deserved promotions at FFL and added five new team members
• FFL was recognized as an Inc. Founder-Friendly Investor, reflecting our long history of collaborating with founders of high-quality middle market businesses

As always, we are grateful for the continued support from all of our investors, colleagues, and friends as we look forward to 2026.

Note: Past performance is not indicative of future results.

* Includes sale of Anova, which was signed in December 2025 and closed in January 2026.